Polysomnographic Findings in Nasal Polyposis
POLYSOMNO
Effects of Endoscopic Sinus Surgery on Sleep Disorder in Patients With Chronic Rhinosinusitis With Polyps
2 other identifiers
interventional
30
1 country
1
Brief Summary
Nasal polyposis (NP) is a chronic inflammatory disease of the nasal and sinus mucosa leading to protrusion of edematous polyps in the nasal cavity. Prevalence of NP among the chronic rhinosinusitis patients is 25-30 %. NP leads to significant limitations in physical, emotional and social aspects of life of the affected patients. Sleep disorder is frequently reported by those patients with impaired nasal breathing. Till now few studies have objectively assessed the impact of NP on sleep quality. the objectives are to figure out sleep disturbances in NP and to analyze the outcomes of sinus surgery on sleep recovering.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 18, 2018
CompletedFirst Posted
Study publicly available on registry
October 31, 2018
CompletedStudy Start
First participant enrolled
January 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedMay 6, 2026
April 1, 2026
6.9 years
October 18, 2018
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Slow-wave sleep duration
Slow-wave sleep duration is measured one month before surgery and 3 months after surgery
1 month before surgery and 3 months postoperatively
Secondary Outcomes (5)
change in total sleep duration
At 1 month before surgery and at 3 months postoperatively
Change in the number of brief wakefulness
At 1 month before surgery and at 3 months postoperatively
change in Apnea-hypopnea index
At 1 month before surgery and at 3 months postoperatively
Change in time with oxygen desaturation below 90%
At 1 month before surgery and at 3 months postoperatively
change in Epworth sleepiness scale scores
At 1 month before surgery and at 3 months postoperatively
Study Arms (1)
endoscopic sinus surgery
EXPERIMENTALSingle group of patients with nasal polyposis eligible for endoscopic sinus surgery
Interventions
Surgical procedure under general anaesthesia: Consists of the removal of bone boundaries between sinus cavities (ethmoidectomy) with nasal polyps resection in order to retrieve nasal patency and sinus drainage Polysomnographic assessment as routinely applied in clinical practice
Eligibility Criteria
You may qualify if:
- Patients who underwent endoscopic sinus surgery for recalcitrant nasal polyposis (failure of a 4-month corticosteroid medical treatment) Social insured patient
- Patient willing to comply with all procedures of the study and its duration
- Patient giving consent
You may not qualify if:
- Patients with previous nasal surgery for nasal polyposis
- Patients with previous continuous positive airway pressure therapy for obstructive sleep apnea
- Non-coverage by the social security scheme
- Patient unable to receive informed information
- Refusal to sign the consent
- Person deprived of the liberty
- Person benefiting from a system of legal protection (guardianship…)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Claude Huriez, CHU
Lille, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Geoffrey Mortuaire, MD
University Hospital, Lille
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 18, 2018
First Posted
October 31, 2018
Study Start
January 17, 2019
Primary Completion
December 1, 2025
Study Completion (Estimated)
December 1, 2026
Last Updated
May 6, 2026
Record last verified: 2026-04